Recent studies have suggested that a high pulse wave velocity (PWV), a measure of aortic stiffness, may be a stronger risk factor for cardiovascular disease (CVD) than a high blood pressure (BP). The relation between insulin, believed to play an important role in the development and clinical course of high BP, and PWV is not yet clear. Therefore, we decided to examine the relationship between insulin and PWV in a large population-based study. The study population consisted of a random sample of 1213 women and 1207 men (age range, 41-72 years) without a history of myocardial infarction or stroke. Fasting insulin was determined together with conventional risk factors for CVD. PWV was recorded transcutaneously by a mechanical electrical principle with one transducer positioned over the left common carotid artery, and another over the left femoral artery. In univariate analysis, insulin was highly significantly related to PWV (standardized regression coefficient: 0.0669 7 0.0051; Po0.001). In multivariate analysis, controlling for all well-established predictors of PWV, such as age, systolic BP or mean BP and pulse pressure, sex, and heart rate, as well as controlling for conventional risk factors for CVD and use of BP-lowering drugs, the level of insulin remained a significant predictor of PWV (standardized regression coefficient: 0.0122 7 0.0048; P ¼ 0.012). In conclusion, the present study found that a higher insulin level was related to a higher PWV. This indicates that hyperinsulinaemia may affect BP and risk of CVD by increasing aortic stiffness.
Introduction
High blood pressure (BP) is an important risk factor for cardiovascular disease (CVD). 1, 2 During the last 10 years, the significance of an elevated systolic blood pressure (SBP) and pulse pressure (PP) in the pathogenesis of CVD has become clear. [3] [4] [5] This has led to growing interest in the mechanical properties of the aorta. 4, 5 A high SBP is closely related to a stiffer aorta. 6, 7 Aortic stiffness can be evaluated noninvasively by measuring pulse wave velocity (PWV) along the descending aorta by ultrasound Doppler techniques. 7 A faster PWV indicates a stiffer aorta. 7 Recently, several studies have been published, which indicate that PWV may be a stronger risk factor for CVD than SBP, [8] [9] [10] [11] and it has been suggested that PWV may represent a useful integrated index of vascular status and hence CVD risk. 11 High insulin level is believed to play an important role in the development and clinical course of high BP and CVD. [12] [13] [14] So far, only a few large studies have examined the relationship between insulin and PWV. [15] [16] [17] [18] Therefore, we decided to examine the relationship between insulin and PWV in a large population-based study. Our general hypothesis was that high insulin level might affect BP and risk of CVD by increasing aortic stiffness.
Materials and methods

Study population
In 1982-1984, a random sample of 4581 Danes from the referral area of Glostrup County Hospital was invited to participate in the MONItoring of trends and determinants in Cardiovascular Disease (MON-ICA) 1 health survey. 19 For the MONICA protocol, participants were selected to represent an equal number of men and women aged 30, 40, 50, and 60 years. Eventually, 3785 participated. In 1993-1994, the participants were reinvited to form a new baseline for a new follow-up study. Since the first examination, 428 subjects had died and 23 had moved or could not be reached. Of the remaining 4130 subjects, 2656 (64%) were willing to participate in this new study.
For the present study, we selected individuals free of overt CVD. Information on past medical history and use of drugs was obtained from a questionnaire. Subjects with a diagnosis of myocardial infarction or stroke, and subjects taking loop diuretics or digoxin or nitrates were excluded. In addition, diabetic subjects on insulin were excluded. In total, 1213 women and 1207 men in general good health were included in this study. The study was conducted in accordance with the Second Helsinki Declaration and approved by the ethics committee for Copenhagen County. Written informed consent was obtained from all participants.
Measurements
Aortic stiffness was estimated by measurements of PWV, an established method to determine arterial stiffness. 6, 7 PWV was recorded transcutaneously by two piezoelectrical pressure transducers. 20 One transducer was positioned over the left common carotid artery and another over the left femoral artery. Two pressure waves were then recorded, and the PWV was determined as PWV ¼ L/T, in which variable L represents the travel distance between the two transducers and T represents the transit time. L was measured on the body surface. PWV was measured right after the measurement of sitting blood pressure.
Fasting concentrations of insulin, glucose, and lipids were analysed by standard methods. 21, 22 Albuminuria was determined as the albumin/ creatinine ratio in a morning urine specimen, as described elsewhere, 23 and a cutoff point X1.16 mg/mmol was defined as microalbuminuria.
BP was measured in the sitting position after 5 min of rest using a mercury sphygmomanometer. The mean of two values was used for SBP and diastolic BP (DBP) measurements. Left ventricular mass was determined from a standard M-mode left parasternal echocardiographic recording. The mass of the left ventricle was calculated by Penn convention. 24 Resting heart rate (HR) was calculated by counting the radial pulse in 15 s and multiplying with 4.
Body mass index (BMI) (kg/m 2 ) was calculated from measurements of height and weight, and the waist-to-hip ratio was calculated from measurements of the circumferences located between the lower rib and the iliac crest and the widest area of the hip, respectively.
Information about smoking, leisure time physical activity, and drinking habits was obtained from a questionnaire. In our analysis, the population was divided into current smokers and nonsmokers. With respect to leisure time physical activity, participants classified themselves as sedentary or slightly active, less than 4 h per week, defined as the low physical activity group, or physically more active, defined as the high physical activity group. Total weekly consumption of alcohol was calculated with the use of questionnaire items regarding average alcohol consumption on weekdays and weekends. Intakes of beer, wine, and spirits were reported separately. The data are presented as beverages per week or X5 or o5 beverages per day.
Statistical analysis
All analyses were performed with the Statistical Analysis System (SAS), version 8.2. Variables of interest were expressed as means 7 s.d., median (range), or frequency in per cent. All statistical tests were two-sided and the significance level was chosen as Po0.05. Since the distribution of PWV was skewed, differences in PWV between categorical variables were tested using nonparametric statistic. To identify significant relationships between PWV and the many variables of interest, we performed both univariate and multivariate analyses using general linear models. The results from our general linear models are expressed as standardized regression coefficients 7 s.e. To fulfil the model assumptions of normal distribution of residuals and lack of relation between predicted values of residuals, PWV, insulin, glucose, VLDL cholesterol, and triglycerides were log-transformed. Also, the distribution of alcohol consumption was markedly skewed in our study population, but since several subjects did not consume alcohol, alcohol consumption was not log-transformed but entered as X5 or o5 beverages per day in our multivariate models. Finally, possible interactions between insulin and variables of interest were investigated, and interaction terms were included in our models if they had an independent biological basis.
Results
General characteristics of the study population are shown in Table 1 . Altogether, 5% of the study population had a fasting plasma glucose level 45.8 mmol/l and 1% had a fasting glucose level 410.3 mmol/l; 5% had a SBP 4163 mmHg and 1% had a SBP 4180 mmHg; 5% had a DBP 4100 mmHg, and 1% had a DBP 4110 mmHg. In total, 48 subjects had a history of type II diabetes and 191 subjects were treated for hypertension. Concerning drugs known to affect insulin, glucose and lipid metabolism, 77 subjects were treated with beta-blockers and 124 subjects were treated with thiazide diuretics.
Standardized regression coefficients and ageadjusted standardized regression coefficients between PWV and various CV risk factors are summarized in Table 2 . In univariate analysis, all factors listed were significantly related to PWV with standardized regression coefficients between 0.151 7 0.0042 and 0.0452 7 0.0051. The strongest univariate relationships were found between PWV and SBP and between PWV and age. Insulin was related to PWV with a standardized regression coefficient of 0.0669 7 0.0051 (Po0.001). In the age-adjusted analysis, all factors listed were still significantly related to PWV, although adjustment for age led to a decrease in the strength of the relationships between PWV and the various risk factors except for HDL cholesterol, and the strongest relationships were still found between PWV and SBP or mean BP. In the present study population, insulin was related to SBP and DBP with standardized regression coefficients of 0.265 7 0.020 and 0.296 7 0.019 (Po0.001), respectively.
In Table 3 , it is seen that men had higher PWV than women, and that subjects treated for type II diabetes or hypertension had higher PWV than others. In addition, subjects with microalbuminuria had higher PWV than subjects without microalbuminuria. It is also seen that smokers had lower PWV than nonsmokers, and that physical activity was not related to PWV. Finally, it is seen that subjects with a daily intake of X5 beverages per day had a higher PWV than subjects with a daily intake of o5 beverages per day.
The results of our multivariate analyses are summarized in Tables 4 and 5 . Because of close statistical relationships between SBP and mean BP, and DBP and mean BP, our first multivariate model, summarized in Table 4 , included SBP and DBP as BP variables, whereas our second model, summarized in Table 5 , included mean BP and PP. It is seen in Tables 4 and 5 that insulin was still significantly associated with PWV after controlling for all wellestablished predictors of PWV, such as age, SBP or mean BP and PP, heart rate, and sex, and after controlling for conventional risk factors for CVD, treatment of hypertension and a history of type II diabetes as well. Insulin was also still significantly related to PWV if individual drugs used to treat hypertension were entered in our models instead of the categorically defined variable: treatment of hypertension (standardized regression coefficient ¼ 0.0123 7 0.0048; P ¼ 0.011). Insulin was also still significantly related to PWV if only subjects with a fasting glucose level o5.8 mmol/l, free of CVD and without a diagnosis of type II diabetes, and not taking drugs affecting lipids, glucose and BP (n ¼ 2068) were included in our models (standardized regression coefficient ¼ 0.0103 7 0.0050; Po0.05). It should be noted here that glucose was not significantly related to PWV in our multivariate models. However, if a diagnosis of diabetes was not included in our models, the relationship between glucose and PWV became highly significant, a manoeuvre that did not affect the relationship between insulin and PWV in our models (data not shown).
Finally, we did find a significant interaction between insulin and age in our study. After multivariate adjustment, the relationship between insulin and PWV was strongest in the elderly. In contrast, we did not find any significant interaction between insulin and sex, insulin and BP, insulin and treatment of hypertension, and insulin and type II diabetes. However, since we do not at present have a biological basis for the interaction between age and insulin, we have not included the interaction term: age Â log of insulin in our final models shown in Tables 4 and 5 .
Discussion
The new finding in the present study was that insulin was significantly related to PWV after adjustment was made for all well-established predictors of PWV, such as age, SBP or mean BP and PP, sex and HR, [15] [16] [17] [18] 25, 26 as well as for conventional risk factors for CVD and use of BP-lowering drugs. As in other studies, the present study confirmed that the major determinants of PWV are age and SBP or mean BP. [15] [16] [17] [18] 25, 26 Another noticeable result in the present study was that LDL cholesterol, believed to be the leading atherogenic particle in plasma, 27 was not significantly related to PWV in multivariate analysis. This finding is consistent with the results from other larger studies, [15] [16] [17] [18] and indicates that aortic stiffness may be relatively independent of a lipid-dominated atherosclerotic process. In this context, it should also be noted that LDL cholesterol per se is not related to high BP. 1 Several other studies have examined the relationship between insulin and arterial stiffness. [15] [16] [17] [18] [28] [29] [30] [31] [32] [33] Many different methods and indices have been used Table 4 because P>0.05: log of VLDL cholesterol, LDL cholesterol, HDL cholesterol, log of triglycerides, log of glucose, history of diabetes, diastolic BP, treatment of hypertension, BMI, waist/hip ratio, microalbuminuria, left ventricular mass index, smoking, alcohol consumption; X vs o5 beverages per day, physical activity.
Insulin and aortic stiffness TW Hansen et al to estimate arterial stiffness making direct comparison of results difficult. Generally, a positive association has been found between insulin levels and arterial stiffness, but in many of these studies no adequate adjustments for HR were made. [28] [29] [30] [31] [32] [33] However, in the three recently published studies, using the same methods as in the present study to measure PWV, no independent relationship between insulin and PWV could be identified after adjustment was made for SBP or mean BP, HR, sex, and age, [10] [11] [12] so at first glance our findings are not consistent with these results. Another finding that at first glance appears to be in contrast with the findings in the present study comes from Yki-Jarvinen and coworkers, who in different groups of subjects have shown that infusion of insulin producing acute hyperinsulinaemia leads to a marked decrease in large arterial stiffness. 34, 35 However, it should be pointed out that it could be difficult to compare the results from a dynamic research setting with acute changes in insulin levels with the results from a statistic research setting with fasting insulin levels as in the present study. Further at second glance, it appears that some sort of agreement exists between our results and the results from Yki-Jarvinen's group. Yki-Jarvinen and co-workers found that subjects with insulin resistance (and therefore also with higher fasting insulin levels) showed resistance to the normal acute insulin-induced decrease in large artery stiffness, 36 so both our study and YkiJarvinen's study found abnormalities in arterial stiffness in subjects with high insulin levels. Finally, our results also get some support from the work by Van Dijk et al, 37 who found that higher fasting insulin levels (but not fasting glucose levels) at baseline were associated with an increase in large arterial stiffness over a 3-year follow-up period in men.
Given the fact that our results are not in agreement with the results of other similar studies, [15] [16] [17] [18] what are the limitations and strength of the present study? Our information on smoking, alcohol use, and physical activity was based on questionnaires, and therefore there may be a reporting bias. The strength of this study was its very large sample size and its base in the general population ensuring the inclusion of a wide range of different individuals. In this context, it should be noted that in our population the prevalence of type II diabetes and hypertension was substantially lower than in other studies. [16] [17] [18] All these factors may explain why the present study could identify insulin as an independent predictor of PWV, whereas other studies failed to do so. [15] [16] [17] [18] Another major strength of the present study was that we actually could identify insulin as an independent predictor of PWV in an analysis including a series of CVD risk factors known to be very closely associated with the presence of high insulin levels, such as a higher waist-to-hip ratio, a higher BMI, a higher BP and presence of hypertension, a higher HR, a higher glucose and triglyceride and VLDL cholesterol level, and a lower HDL cholesterol level, a lower level of physical activity, and a diagnosis of diabetes (all the metabolic and lifestyle factors that together with hyperinsulinaemia constitute or relate to the metabolic syndrome X). 12, 13 If all these risk factors, for which high insulin levels could be operating as a mediator, were not included in our multivariate model, the strength of the relationship between insulin and PWV increased substantially (standardized regression coefficient ¼ 0.0340 7 0.0044; P ¼ o0.001 (model R 2 0.41) vs 0.0122 7 0.0048; P ¼ 0.012 (model R 2 0.52, see Table 4 or 5)). Since a high insulin level can be identified as a significant predictor of PWV, what is the pathogenetic link between hyperinsulinaemia and aortic stiffness? A high insulin level is believed to play an important role in the development and clinical course of high BP and CVD. [12] [13] [14] 38, 39 The proposed mechanisms by which insulin may affect BP involve an increase in sympathetic nervous system activation and sodium reabsorption. 12, 38, 39 Since a high insulin level is associated with both a higher BP 12, 13, 38, 39 and HR, 40 two important determinants of aortic stiffness, [15] [16] [17] [18] 25, 26 insulin may of course affect aortic stiffness through these two factors. However, since our study found a significant relationship between insulin and PWV after adjustment for BP and HR, a direct action of insulin on the arterial wall may be involved. This notion is supported by studies indicating that insulin promotes the synthesis of collagen and stimulates hyperplasia and hypertrophy of vascular smooth muscle cells. 39, 41, 42 Finally, it should be acknowledged that since some of the confounding variables, such as smoking and physical activity, were determined in a rather imprecise manner we cannot rule out the possibility that high insulin levels in the present study population was actually a marker of something unmeasured.
In conclusion, the present study found that hyperinsulinaemia was related to a higher PWV. This finding suggests that hyperinsulinaemia may affect BP and risk of CVD by increasing aortic stiffness. Table 4 footnote.
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